KIAA0240 Activators
KIAA0240 Activators are a class of chemical compounds that enhance the functional activity of KIAA0240, a protein involved in the PI3K/AKT signaling pathway. Some KIAA0240 activators, such as EGF and insulin, are growth factors that bind to their respective receptors, triggering the PI3K/AKT pathway and leading to the enhanced functional activity of KIAA0240. The action of these growth factors exemplifies how receptor-ligand interactions can activate intracellular signaling cascades, leading to the enhanced functional activity of KIAA0240.
Other KIAA0240 activators act through different mechanisms, but all lead to the enhanced functional activity of KIAA0240 within the PI3K/AKT pathway. NVP-BEZ235 is an inhibitor of PI3K and mTOR,elements of the PI3K/AKT pathway, and their inhibition can lead to the enhanced functional activity of KIAA0240. Similarly, AKT inhibitors including Ipatasertib, Triciribine, Perifosine, Akti-1/2, and MK-2206, can also enhance the functional activity of KIAA0240 by inhibiting AKT, a key component of the PI3K/AKT signaling pathway. These inhibitors highlight the importance of the PI3K/AKT pathway in the functional activity of KIAA0240 and demonstrate how modulation of this pathway can lead to the enhanced functional activity of KIAA0240.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin triggers the PI3K/AKT signaling pathway, which is known to be involved in the functional activity of KIAA0240. By activating this pathway, insulin can enhance the functional activity of KIAA0240. | ||||||
(2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone | sc-501166 | 5 mg | $540.00 | |||
Ipatasertib is an AKT inhibitor that can enhance the functional activity of KIAA0240 by inhibiting AKT, a kinase involved in the PI3K/AKT pathway, which KIAA0240 is part of. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine is an AKT inhibitor that can enhance the functional activity of KIAA0240 by inhibiting AKT, a crucial component of the PI3K/AKT pathway, which KIAA0240 is involved in. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $188.00 $327.00 | 1 | |
Perifosine is an AKT inhibitor that can enhance the functional activity of KIAA0240 by inhibiting AKT, a component of the PI3K/AKT signaling pathway, in which KIAA0240 plays a role. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
NVP-BEZ235 is a dual inhibitor of PI3K and mTOR. By inhibiting these key components of the PI3K/AKT pathway, NVP-BEZ235 can enhance the functional activity of KIAA0240. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $208.00 $270.00 | 29 | |
Akti-1/2 is an inhibitor of AKT1 and AKT2. By inhibiting these kinases, Akti-1/2 can enhance the functional activity of KIAA0240, given its role in the PI3K/AKT signaling pathway. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is an allosteric inhibitor of AKT. By inhibiting AKT, MK-2206 can enhance the functional activity of KIAA0240, as KIAA0240 is involved in the PI3K/AKT signaling pathway. | ||||||